Recon: Brazil’s Anvisa allows J&J to resume COVID-19 vaccine trial; BMS reports positive Phase III for novel psoriasis drug
Posted 03 November 2020 | By Michael Mezher Welcome to Regulatory Reconnaissance, your daily regulatory news and intelligence briefing. In Focus: US Experts to review Biogen drug that could be first new Alzheimer’s treatment in decades (Reuters) FDA bars critic from review panel of Biogen’s …
Read More